SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is experiencing significant volatility and downward pressure as investors grow increasingly concerned over the company's massive debt load and heavy capital expenditures dedicated to building out AI infrastructure. While some in the community see the recent price drop as a deep-value opportunity based on strong contracted revenue and long-term cloud potential, many others are fearful of execution risks, the company's reliance on major AI partners, and the potential for further technical breakdowns.

Direxion Shares ETF Trust - Direxion Daily MSCI South Korea Bull 3X ETF

Direxion Daily South Korea Bull 3X Shares

KORU is experiencing extreme volatility driven by a 20-for-1 forward stock split, anticipation surrounding major South Korean semiconductor IPOs, and heavy margin-related liquidations among retail traders. Community sentiment is deeply divided, with many traders debating whether the stock's sharp technical swings represent a long-term bottom or a high-risk gamble fueled by excessive leverage.

Q32 Bio, Inc. operates as a clinical stage biotechnology company developing biologic therapeutics targeting potent regulators of the innate and adaptive immune systems to re-balance immunity in autoimmune and inflammatory diseases. It focuses on the IL-7 / TSLP receptor pathways and complement system, addressing immune dysregulation to help patients take back control of their lives. The company was founded by David Grayzel and Shelia Violette in 2017 and is headquartered in Waltham, MA.

Q32 Bio Inc.

Q32 Bio Inc. is experiencing significant market volatility driven by positive Phase 2a clinical data for its alopecia areata candidate, bempikibart, which has sparked discussions about potential long-term value and analyst price target upgrades. However, the excitement is tempered by community concerns regarding a major public offering and general biotech sector risks, with traders debating whether this clinical win can sustain momentum or lead to further dilution.

Taiwan Semiconductor Manufacturing Co., Ltd. engages in the manufacture and sale of integrated circuits and wafer semiconductor devices. Its chips are used in personal computers and peripheral products, information applications, wired and wireless communications systems products, and automotive and industrial equipment including consumer electronics such as smartphones, digital television, game consoles, and digital cameras. The company was founded by Chung Mou Chang on February 21, 1987 and is headquartered in Hsinchu, Taiwan.

Taiwan Semiconductor Manufacturing - ADR

Taiwan Semiconductor Manufacturing is in the spotlight as investors track its critical role in the global AI infrastructure buildout, with community sentiment shifting between optimism over its record revenue growth and caution regarding geopolitical risks and potential capacity constraints. Traders are heavily monitoring upcoming earnings and guidance, treating recent price action as a consolidation period while betting on the company's long-term dominance as the primary foundry for leading-edge AI chips.

Citigroup, Inc. is a holding company, which engages in the provision of financial products and services. It operates through the following segments: Services, Markets, Banking, Wealth, U.S. Personal Banking (USPB), and All Other. The Services segment includes Treasury and Trade Solutions (TTS) which provides an integrated suite of tailored cash management, trade, and working capital solutions to multinational corporations, financial institutions and public sector organizations, and Securities Services, which offers cross-border support for clients, providing on-the-ground local market expertise, post-trade technologies, customized data solutions, and a wide range of securities services solutions that can be tailored to meet client needs. The Markets segment provides corporate, institutional, and public sector clients around the world with a full range of sales and trading services across equities, foreign exchange, rates, spread products, and commodities. The Banking segment offers Investment Banking and Corporate Lending services. The Wealth segment includes Private Bank, Wealth at Work, and Citigold and provides financial services to a range of client segments through banking, lending, mortgages, investment, custody, and trust product offerings. The USPB segment includes Branded Cards and Retail Services, which have proprietary card portfolios and co-branded card portfolios within Branded Cards, and co-brand and private label relationships within Retail Services. The All Other segment consists of activities not assigned to the reportable operating segments, including certain unallocated costs of global functions, other corporate expenses, and net treasury results. The company was founded in 1812 and is headquartered in New York, NY.

Citigroup Inc

Citigroup is in the spotlight as investors digest recent fourth-quarter earnings that beat adjusted estimates but failed to satisfy market expectations due to concerns over expenses and capital positioning. The stock is also facing continued pressure from broader financial sector headwinds, including recent regulatory discourse regarding potential interest rate caps on credit cards.

Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of therapeutics for metabolic dysfunction-associated steatohepatitis. The company was founded by Rebecca A. Taub, Frederick Bernard Craves, and Edward Chiang on March 10, 2000 and is headquartered in West Conshohocken, PA.

Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals is drawing intense community attention due to ongoing M&A speculation, with investors debating whether the company will be acquired by a major pharmaceutical player or continue its strategy of independent growth and pipeline expansion. Retail sentiment remains divided between excitement over the potential for a high-premium buyout and frustration over management's heavy spending on pipeline development instead of prioritizing near-term profitability.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund is trending as investors react to escalating geopolitical instability in the Strait of Hormuz, where ongoing military strikes and the threat of blockade are fueling high volatility in energy markets. Community discourse remains deeply divided between traders capitalizing on the heightened fear and those expressing skepticism over the perceived manipulation of oil prices through contradictory diplomatic headlines and government reserves.

Select Sector SPDR Trust (The) - State Street Energy Select Sector SPDR ETF

Energy Select Sector SPDR Fund

Energy Select Sector SPDR Fund (XLE) is trending as the energy sector sees significant capital rotation and bullish momentum amid ongoing geopolitical tension in the Strait of Hormuz. Investors are actively debating the impact of supply chain disruptions on fuel inventory levels while monitoring the sector's relative strength against weakening growth-oriented leadership.

Wells Fargo & Co. is a diversified and community-based financial services company, which engages in the provision of banking, insurance, investments, mortgage, and consumer and commercial finance products and services. It operates through the following segments: Consumer Banking and Lending, Commercial Banking, Corporate and Investment Banking, and Wealth and Investment Management. The Consumer Banking and Lending segment offers consumer and small business banking, home lending, credit cards, auto, and personal lending. The Commercial Banking segment provides banking and credit products across industry sectors and municipalities, secured lending and lease products, and treasury management. The Corporate and Investment Banking segment is composed of corporate banking, investment banking, treasury management, commercial real estate lending and servicing, and equity and fixed income solutions, as well as sales, trading, and research capabilities. The Wealth and Investment Management segment refers to personalized wealth management, brokerage, financial planning, lending, private banking, trust, and fiduciary products and services. The company was founded by Henry Wells and William G. Fargo on March 18, 1852 and is headquartered in San Francisco, CA.

Wells Fargo & Co.

Wells Fargo is trending as market participants monitor the financial sector ahead of upcoming earnings reports, with investors closely watching for insights into consumer credit health and the bank's operational trajectory following the removal of regulatory asset caps. Community discussions are heavily focused on navigating volatility in bank stocks, balancing earnings expectations against broader economic indicators like inflation and potential regulatory shifts in credit card interest rates.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

Merck & Co. is currently trending as speculation intensifies regarding potential biotech acquisitions intended to bolster its oncology pipeline ahead of the looming patent cliff for Keytruda. The investor community is actively debating the likelihood of a buyout for companies like Sellas Life Sciences and Inhibrx, as Merck seeks to secure innovative cancer platforms to maintain its market dominance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Accretion Acquisition Corp. is a blank check company. It engages in the business of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. The company was founded on February 26, 2021 and is headquartered in Denver, CO.

Accretion Acquisition Corp

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Fundamentals

Info

ENERAccretion Acquisition Corp

Latest ENER News